Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.33 USD | +1.24% | +1.85% | -7.15% |
05-31 | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) | |
05-14 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-7.15% | 10.97B | - | ||
+13.73% | 130B | A- | ||
-4.33% | 8.42B | C | ||
+41.80% | 5.57B | B+ | ||
-21.94% | 4.59B | C | ||
+7.81% | 3.42B | C- | ||
-10.26% | 2.73B | B- | ||
-10.29% | 2.08B | - | - | |
-13.58% | 1.92B | - | ||
-27.77% | 1.66B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- SNN Stock
- Ratings Smith & Nephew plc